HIV status and the risk of ischemic stroke among men

Neurology

Volumn 84, Issue 19, 2015, Pages 1933-1940

  Sico, Jason J ^a,b   Chang, Chung Chou H ^c   So Armah, Kaku ^b   Justice, Amy C ^a,b   Hylek, Elaine ^d   Skanderson, Melissa ^a   McGinnis, Kathleen ^a   Kuller, Lewis H ^c   Kraemer, Kevin L ^c   Rimland, David ^e   Bidwell Goetz, Matthew ^f   Butt, Adeel A ^c,g   Rodriguez Barradas, Maria C ^h   Gibert, Cynthia ⁱ   Leaf, David ^f   Brown, Sheldon T ^j,k   Samet, Jeffrey ^l   Kazis, Lewis ^m   Bryant, Kendall ⁿ   Freiberg, Matthew S ^o  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d BOSTON MEDICAL CENTER   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h BAYLOR COLLEGE OF MEDICINE   (United States)

ⁱ GEORGE WASHINGTON UNIVERSITY   (United States)

^j James J Peters VAMC   (United States)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^m BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^o VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; ORAL ANTIDIABETIC AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CLINICAL ASSESSMENT; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; DISEASE DURATION; ETHNICITY; FOLLOW UP; HAZARD RATIO; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STROKE PATIENT; SUBSTANCE USE; VETERAN; CAUSALITY; HIV INFECTIONS; MEN'S HEALTH; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; STROKE; UNITED STATES;

BRAIN ISCHEMIA; CAUSALITY; COHORT STUDIES; COMORBIDITY; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; MEN'S HEALTH; MIDDLE AGED; RISK FACTORS; STROKE; UNITED STATES; VETERANS;

EID: 84929150985     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000001560     Document Type: Article

References (34)

1. Freiberg M, Cheng DM, Kraemer KL, Saitz R, Kuller LH, Samet JH. The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS 2007;21:193-197.
2. Justice AC, Zingmond DS, Gordon K, et al. Drug toxicity, HIV progression, or comorbidity of aging: does tipranavir use increase the risk of intracranial hemorrhage? Clin Infect Dis 2008;47:1226-1230.
3. Freiberg MS, Chang CH, Kuller LH. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med 2013;173:614-622.
4. Strategies for Management of Antiretroviral Therapy (SMART) Study Group, El-Sadr WM, Lundgren J, et al. CD41 count-guided interruption of antiretroviral treatment. N Engl J Med 2006;355:2283-2296.
5. D:A:D Study Group, Sabin CA, Worm SW, et al. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet 2008; 371:1417-1426.
6. Pinto AN. AIDS and cerebrovascular disease. Stroke 1996; 27:538-543.
7. Qureshi AI, Janssen RS, Karon JM, et al. Human immunodeficiency virus infection and stroke in young patients. Arch Neurol 1997;54:1150-1153.
8. Adams RJ, Albers G, Alberts MJ, et al. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke 2008;39:1647-1652.
9. Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antiviral Res 2001;51:151-177.
10. Bedimo RJ, McGinnis KA, Dunlap M, Rodriguez-Barradas MC, Justice AC. Incidence of non-AIDSdefining malignancies in HIV-infected versus noninfected patients in the HAART era: impact of immunosuppression. J Acquir Immune Defic Syndr 2009;52:203-208.
11. Freiberg MS, Chang CC, Skanderson M, et al. The risk of incident coronary heart disease among veterans with and without HIV and hepatitis C. Circ Cardiovasc Qual Outcomes 2011;4:425-432.
12. Lee MH, Yang HI, Wang CH, et al. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 2010;41:7.
13. Di Napoli M, Schwaninger M, Cappelli R, et al. Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke: a statement for health care professionals from the CRP Pooling Project members. Stroke 2005;36:1316-1329.
14. Cole JW, Pinto AN, Hebel JR, et al. Acquired immunodeficiency syndrome and the risk of stroke. Stroke 2004;35:51-56.
15. Hoffmann M, Berger JR, Nath A, Rayens M. Cerebrovascular disease in young, HIV-infected, black Africans in the KwaZulu Natal province of South Africa. J Neurovirol 2000;6:229-236.
16. Mateen FJ, Post WS, Sacktor N, et al. Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men. Neurology 2013;81: 2094-2102.
17. Chow F, Regan S, Feske S, Meigs JB, Grinspoon SK, Triant VA. Comparison of ischemic stroke incidence in HIV-infected and non-HIV-infected patients in a US health care system. J Acquir Immune Defic Syndr 2012; 60:351-358.
18. Marcus JL, Leyden WA, Chao CR, et al. HIV infection and incidence of ischemic stroke. AIDS 2014;28: 1911-1919.
19. Fultz SLM, Skanderson MM, Mole LAP, et al. Development and verification of a "virtual" cohort using the National VA Health Information System. Med Care 2006;44:S25-S30.
20. Ives DG, Fitzpatrick AL, Bild DE, et al. Surveillance and ascertainment of cardiovascular events: the Cardiovascular Health Study. Ann Epidemiol 1995;5:278-285.
21. Ekundayo OJ, Vassar SD, Williams LS, Bravata DM, Cheng EM. Using administrative databases to calculate Framingham scores within a large health care organization. Stroke 2011;42:1982-1987.
22. Tirschwell DL, Longstreth WT. Validating administrative data in stroke research. Stroke 2002;33:2465-2470.
23. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-1252.
24. Butt AA, McGinnis K, Rodriguez-Barradas MC, et al. HIV infection and the risk of diabetes mellitus. AIDS 2009;23:1227-1234.
25. McGinnis KA, Brandt CA, Skanderson M, et al. Validating smoking data from the Veteran's Affairs Health Factors dataset, an electronic data source. Nicotine Tob Res 2011; 13:1233-1239.
26. Goulet JL, Fultz SL, McGinnis KA, Justice AC. Relative prevalence of comorbidities and treatment contraindications in HIV-mono-infected and HIV/HCV-co-infected veterans. AIDS 2005;19:S99-S105.
27. Kraemer KL, McGinnis KA, Skanderson M, et al. Alcohol problems and health care services use in human immunodeficiency virus (HIV)-infected and HIV-uninfected veterans. Med Care 2006;44:S44-S51.
28. Jensen PN, Johnson K, Floyd J, Heckbert SR, Carnahan R, Dublin S. A systematic review of validated methods for identifying atrial fibrillation using administrative data. Pharmacoepidemiol Drug Saf 2012;21:141-147.
29. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-526.
30. Corral I, Quereda C, Moreno A, et al. Cerebrovascular ischemic events in HIV-1-infected patients receiving highly active antiretroviral therapy: incidence and risk factors. Cerebrovasc Dis 2009;27:559-563.
31. The Antiretroviral Therapy Cohort Collaboration. The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med 2005;165:416-423.
32. Baker JV, Peng G, Rapkin J, et al. CD41 count and risk of non-AIDS diseases following initial treatment for HIV infection. AIDS 2008;22:841-848.
33. Centers for Disease Control and Prevention. Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep 2011;60:1618-1623.
34. Ross JS, Arling G, Ofner S, et al. Correlation of inpatient and outpatient measures of stroke care quality within veterans health administration hospitals. Stroke 2011;42:2269-2275.